Mohamed Hussein, Durayd Alzoubaidi, Michael O'Donnell, Alvaro de la Serna, Paul Bassett, Ioannis Varbobitis, Tricia Hengehold, Jacobo Ortiz Fernandez-Sordo, Johannes W Rey, Bu'Hussain Hayee, Edward J Despott, Alberto Murino, David Graham, Melissa Latorre, Sulleman Moreea, Phillip Boger, Jason Dunn, Inder Mainie, Daniel Mullady, Dayna Early, Krish Ragunath, John Anderson, Pradeep Bhandari, Martin Goetz, Ralf Kiesslich, Emmanuel Coron, Enrique Rodriguez de Santiago, Tamas Gonda, Seth A Gross, Laurence B Lovat, Rehan Haidry
BACKGROUND AND AIM: Upper gastrointestinal tumors account for 5% of upper gastrointestinal bleeds. These patients are challenging to treat due to the diffuse nature of the neoplastic bleeding lesions, high rebleeding rates, and significant transfusion requirements. TC-325 (Cook Medical, North Carolina, USA) is a hemostatic powder for gastrointestinal bleeding. The aim of this study was to examine the outcomes of upper gastrointestinal bleeds secondary to tumors treated with Hemospray therapy...
November 2021: Journal of Gastroenterology and Hepatology